跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 71 条关于
“ABCB4”
全部
71
临床试验
41
药物
23
机构
0
资讯
7
21天前
Rectify Pharmaceuticals Unveils RTY-406, an Oral Dual ABCB4/BSEP Modulator for Primary Sclerosing Cholangitis
3个月前
Rectify Pharmaceuticals Reports Promising Preclinical Data for RTY-406 in Primary Sclerosing Cholangitis at EASL 2026
去年
Rectify Pharma's Novel Dual-Targeted PFM Shows Promise for Hepatobiliary Diseases at EASL 2025
去年
Ocugen's OCU410ST Receives Orphan Drug Designation from EMA for ABCA4 Retinopathies
去年
Ocugen's OCU410ST Receives EMA Orphan Drug Designation for ABCA4-Associated Retinopathies
去年
Ocugen's OCU410ST Receives EMA Orphan Drug Designation for ABCA4-Associated Retinopathies
去年
EMA Grants Orphan Drug Designation to Ocugen's OCU410ST for ABCA4-Associated Retinopathies